Clinical Trial Update: ARTS - AVODART After Radical Therapy For Prostate Cancer Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dutasteride (AVODART) after radical therapy for prostate cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate, Prostate Cancer After a Radical Treatment | Phase 2 | Status: COMPLETED | Results posted: 2011-12-13